These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38030314)

  • 41. [100 years of sickle cell research: current knowledge and future perspectives].
    Bégué P
    Med Trop (Mars); 2010 Dec; 70(5-6):421-2. PubMed ID: 21520637
    [No Abstract]   [Full Text] [Related]  

  • 42. Health care priority and sickle cell anemia.
    Scott RB
    JAMA; 1970 Oct; 214(4):731-4. PubMed ID: 5536114
    [No Abstract]   [Full Text] [Related]  

  • 43. Managed Care, Hospital Characteristics, and Inpatient Utilization for Sickle Cell Disease Patients.
    Lewit E; Thirumalai K; Wang CJ
    J Gen Intern Med; 2018 Dec; 33(12):2053-2055. PubMed ID: 30128790
    [No Abstract]   [Full Text] [Related]  

  • 44. Sickle cell disease in Grenada: Quality of life and barriers to care.
    Grygiel A; Ikolo F; Stephen R; Bleasdille D; Robbins-Furman P; Nelson B; Sobering AK; Elsea SH
    Mol Genet Genomic Med; 2021 Jan; 9(1):e1567. PubMed ID: 33332776
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of Sickle Cell Disease Super Utilizers.
    Johnson GA
    West J Emerg Med; 2017 Feb; 18(2):251-252. PubMed ID: 28210360
    [No Abstract]   [Full Text] [Related]  

  • 46. Sickle-cell disease.
    Serjeant GR
    Lancet; 1997 Sep; 350(9079):725-30. PubMed ID: 9291916
    [No Abstract]   [Full Text] [Related]  

  • 47. [Neonatal screening for sickle cell disease at the Nice University Hospital: the last 8 years].
    Berthet S; Monpoux F; Soummer AM; Bérard E; Sarles J; Badens C
    Arch Pediatr; 2010 Dec; 17(12):1652-6. PubMed ID: 21087846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sickle cell anemia from central India: a retrospective analysis.
    Jain D; Italia K; Sarathi V; Ghoshand K; Colah R
    Indian Pediatr; 2012 Nov; 49(11):911-3. PubMed ID: 22728629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravenous support for the patient in sickle cell crisis.
    Odesina V
    J Intraven Nurs; 2001; 24(1):32-7. PubMed ID: 11836842
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is treatment adherence associated with better quality of life in children with sickle cell disease?
    Barakat LP; Lutz M; Smith-Whitley K; Ohene-Frempong K
    Qual Life Res; 2005 Mar; 14(2):407-14. PubMed ID: 15892429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [2nd International Symposium on Sickle Cell Disease in Central Africa].
    Ngasia B; Kazadi G; Loko G; Sica L; Wamba G; Gonzalez JP; Tshilolo L
    Med Trop (Mars); 2011 Dec; 71(6):535-6. PubMed ID: 22393614
    [No Abstract]   [Full Text] [Related]  

  • 52. Preface: Thematic issue on sickle cell disease.
    Goodman SR
    Cell Mol Biol (Noisy-le-grand); 2004 Feb; 50(1):1-4. PubMed ID: 15040422
    [No Abstract]   [Full Text] [Related]  

  • 53. Understanding and meeting the hospitalist's challenge: caring for adults with sickle cell disease.
    Tanabe P; Ogunseitan A
    J Hosp Med; 2011 May; 6(5):245-7. PubMed ID: 21661097
    [No Abstract]   [Full Text] [Related]  

  • 54. Sickle Cell Disease and the Kidney: Filters Gone Awry.
    Lebensburger JD; Derebail VK
    Hematol Oncol Clin North Am; 2022 Dec; 36(6):1239-1254. PubMed ID: 36400541
    [TBL] [Abstract][Full Text] [Related]  

  • 55. COVID-19 and sickle cell disease.
    Menapace LA; Thein SL
    Haematologica; 2020 Nov; 105(11):2501-2504. PubMed ID: 33131239
    [No Abstract]   [Full Text] [Related]  

  • 56. Social determinants of health: the next frontier for improving care and outcomes in sickle cell disease.
    Porter JS; Heitzer AM; Crosby LE; Hankins JS
    Lancet Haematol; 2023 Aug; 10(8):e571-e573. PubMed ID: 37451302
    [No Abstract]   [Full Text] [Related]  

  • 57. Profile of Medicaid enrollees with sickle cell disease: A high need, high cost population.
    Grady A; Fiori A; Patel D; Nysenbaum J
    PLoS One; 2021; 16(10):e0257796. PubMed ID: 34705847
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ending the burden of sickle cell disease in Africa.
    Moeti MR; Brango P; Nabyonga-Orem J; Impouma B
    Lancet Haematol; 2023 Aug; 10(8):e567-e569. PubMed ID: 37451305
    [No Abstract]   [Full Text] [Related]  

  • 59. Sickle cell disease: challenging the past, looking to the future.
    Cela E
    An Pediatr (Engl Ed); 2022 Jul; 97(1):1-3. PubMed ID: 35752585
    [No Abstract]   [Full Text] [Related]  

  • 60. Value of a cure for sickle cell disease in reducing economic disparities.
    Graf M; Tuly R; Gallagher M; Sullivan J; Jena AB
    Am J Hematol; 2022 Aug; 97(8):E289-E291. PubMed ID: 35604241
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.